Tuesday, 25 March 2014

One size does not fit all glycemic targets for type 2 diabetes

The present paper briefly reviews the rationale and the clinical trials that support specific glycemic goals towards a ‘tailored’ approach for the management of hyperglycemia in diabetes (Journal of Diabetes Investigation)

Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus

Type 2 diabetes-specific plasma and urine metabolites were discovered that predict the development of macroalbuminuria beyond established renal risk markers (Diabetic Medicine)

No comments:

Post a Comment